Valirx Stock Quote VAL - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
UK
LSE
Valirx Plc (VAL) Quote

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

2.20

Bid

1.80

Ask

2.00

Volume

1,538,614

1.85 Day's Range 1.90

1.85 52 Week Range 14.75

Market Cap

Previous Close

1.90

Open

1.90

Last Trade

Last Trade Time

Financial Volume

33,850p

VWAP

2.20

Average Volume (3m)

1,122,964

Shares Outstanding

90,174,156

Dividend Yield

-

PE Ratio

-0.73

Earnings Per Share (EPS)

-0.03

Revenue

-

Net Profit

-2.37M

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.valirx.com

Headquarters

London, Gbr

Founded

1970

Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 1.90p. Over the last year, Valirx shares have traded in a share price range of 1.85p to 14.75p.

Valirx currently has 90,174,156 shares outstanding. The market capitalization of Valirx is £1.71 million. Valirx has a price to earnings ratio (PE ratio) of -0.73.

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

ValiRx PLC Further re Final Results

ValiRx PLC 16 May 2024 16 May 2024 VALIRX PLC ("ValiRx" or the "Company") Further re Final Results ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage...

TRADING UPDATES: Vertu Motors ups dividend as hails record revenue

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

ValiRx PLC Final Results and Notice of AGM

ValiRx PLC 15 May 2024 15 May 2024 ValiRx PLC ("ValiRx" or the "Company") Full Year Results and Notice of AGM London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on...

ValiRx PLC Directorate Changes

ValiRx PLC 22 April 2024 ValiRx plc ("ValiRx" or the "Company") Directorate Changes ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer...

ValiRx inks evaluation deal with Imperial College London for research

ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on ...

ValiRx PLC Evaluation Agreement with Imperial College London

ValiRx PLC 21 March 2024 VALIRX PLC ("ValiRx" or the "Company") Initiation of Evaluation project Agreement with Imperial College London ValiRx plc (the "Company") (AIM: VAL), a life sciences...

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

ValiRx PLC Further re Final Results

ValiRx PLC 16 May 2024 16 May 2024 VALIRX PLC ("ValiRx" or the "Company") Further re Final Results ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage...

TRADING UPDATES: Vertu Motors ups dividend as hails record revenue

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

ValiRx PLC Final Results and Notice of AGM

ValiRx PLC 15 May 2024 15 May 2024 ValiRx PLC ("ValiRx" or the "Company") Full Year Results and Notice of AGM London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on...

ValiRx PLC Directorate Changes

ValiRx PLC 22 April 2024 ValiRx plc ("ValiRx" or the "Company") Directorate Changes ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer...

ValiRx inks evaluation deal with Imperial College London for research

ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on ...

ValiRx PLC Evaluation Agreement with Imperial College London

ValiRx PLC 21 March 2024 VALIRX PLC ("ValiRx" or the "Company") Initiation of Evaluation project Agreement with Imperial College London ValiRx plc (the "Company") (AIM: VAL), a life sciences...

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.9	-29.0322580645	3.1	3.15	1.85	3676863	2.08541788	DE
4	-1.25	-36.231884058	3.45	3.45	1.85	1417259	2.46789479	DE
12	-2.3	-51.1111111111	4.5	4.55	1.85	1122964	3.19200443	DE
26	-9.3	-80.8695652174	11.5	13.125	1.85	929545	4.94019576	DE
52	-7.55	-77.4358974359	9.75	14.75	1.85	821457	6.99495777	DE
156	-19.3	-89.7674418605	21.5	64	1.85	993971	20.10410981	DE
260	-12.8	-85.3333333333	15	67.5	1.4	5209062	9.22601356	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M

getmoreshares

getmoreshares 27 seconds ago

https://www.evsv.org/ reposting -- will not need to dig for it

EyeInTheSky

EyeInTheSky 2 minutes ago

So you're saying its going to make new yearly lows after having a record-breaking-volume week? lol

rosemountbomber

rosemountbomber 2 minutes ago

Thanks for posting. I notice that of all the 25 stocks listed, Amarin has the lowest upside projection of 24.5% whereas most of the others are in the hundreds or thousands of percent. Although some of them might come back from the dead, most will not, and I think Amarin is the safest bet of all.

redspinelpinktopaz

redspinelpinktopaz 3 minutes ago

I'm long, that is very disappointed
In marketing, very disjointed
Anxiously awaiting, something hostile
While I'm putting Vicam, in each nostril

InvestK

InvestK 3 minutes ago

Re:Beartrap12

My family and I have held NWBO since mid 2018 and have added some along the way.

I am new on this board as far as posting, however, I do follow the board and truly appreciate your insights.

Regards

actiontime

actiontime 3 minutes ago

Agreed Amigo! I’ve/We’ve been saying this is just the beginning especially with institutional adoption just beginning.
Like i always have said, buy the dip and enjoy the rip! 👍🏻👍🏻

xoom

xoom 4 minutes ago

BTS, ‘initial payment’

Nemesis18

Nemesis18 5 minutes ago

During Prince William latest trip He said: “There is an urgent need for new measures to access new and existing vaccines, diagnostics and medicines.

Allegedly, he then urged patients to travel to Germany where treatment is 1/10th of the cost than in the UK.
Truly making access

jimr1717

jimr1717 6 minutes ago

Speaking of “free money”, I am sure that the seller of the shares that he dumped on you is enjoying his “free money” and is wondering why you haven’t stepped up on the bid so that he can enjoy more “free money”

Lmao idiot

beartrap12

beartrap12 8 minutes ago

QL300, I want to send out a special thanks to you for posting this link to the MHRA's website on the 150-day review. I should have looked it up myself before, but didn't. Everyone should go through this url! I hope I copied it properly. If not, go back to QL 300's post.

https://www

XMaster2023

XMaster2023 8 minutes ago

During Prince William latest trip He said: “There is an urgent need for new measures to access new and existing vaccines, diagnostics and medicines.

I say the next meeting May 30-31. You have less than 2 weeks to cover.

Birch69696969

Birch69696969 8 minutes ago

Maybe we’re not as bad off as previous years. The dilution isn’t bad if they add 34 million shares until May 2025. With more acquisitions coming around the market. Using preferred shares for acquisitions is great but we can still use the common shares if they’re restricted. Trillium will help us wit

cashclan

cashclan 8 minutes ago

Not clinging to anything

Democrats are actively seeking voting for these illigals and also seeking district representation aka more House members via redististicting..

Put away your 💩

Dennboy66

Dennboy66 9 minutes ago

To understand this topic of reimbursement by Medicare, one must understand how they work.

From reading the news, one can see that there is a push for Medicare to be able to negotiate drug prices directly with companies and there is a list of 10 or so drugs that they have been given t

71chris71

71chris71 9 minutes ago

Sooner or later you too will say that Nixon is a dishonest person.... "It's just a matter of time "as many of you write here

ka ching

ka ching 10 minutes ago

Thanks for all the nice posts She just got transferred to ICU as having a hard time breathing and waiting to see her Of course Henry doesnt care as i told him Thanks but no reply of course And told him to add another one to his list of heart attacks

nyt

nyt 10 minutes ago

So, reading your post, that must mean that had you the money, you would immediately buy the patents, right?

jimr1717

jimr1717 11 minutes ago

Perhaps because it’s the weekend you might have the time to figure out who the winner is

In the “Bag Holding” Contest.

I think that you will find that it’s a landslide on

The CONdog96 🤡©️ Clown.

It would be hard to find

mrwrn2010

mrwrn2010 11 minutes ago

I’m not sure, not an expert on the process. I assumed they typically filed all together for all the dosages they could confidently replicate and successfully trial as bio equivalent.

B402

B402 12 minutes ago

"How hard is it to meet in the middle and not be stupid about shit"

[yt]m36e0A_XneI[/yt]

cashclan

cashclan 13 minutes ago

Supreme Court

Overturned roe/wade not Trump. There are women on that court. Simply was a bad law.

Trump position is it is a state by state choice. Something the Fed government should be involved with.

There are zero insurance companies t

attilathehunt

attilathehunt 13 minutes ago

Someone always sell the shares in last minute

Yes, the lower the close the less interest they pay on their borrowed shares...The MM's are the big shorts and thus they help themselves by closing it lower....This won't change until approval.

beartrap12

beartrap12 13 minutes ago

Thank you, IinvestK. Your name is new to me and I see you have only a few recent comments on NWBO blog. Hope you stay positive despite the armies of naysayers here!

Ecomike

Ecomike 13 minutes ago

It will happen.

Mackenzie Dveled exNorth...

Mackenzie Emerging Marke...

John Q. Hammons

Mainz BioMed NV

Vanguard Pennsylvania Tax-Exempt

Lineage Cell Therapeutics

Boulder Growth and Income

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions